Abstract:Aim: Although aberrant miRNAs expression has been documented, altered miR-100 expression in cervical cancer and precursor tissues and its carcinogenic effect and mechanism remain unexplored. The aim of our study was to investigate the role of miR-100 alteration in cervical carcinogenesis.Methods: The expression of miR-100 was examined by quantitative real-time reverse transcriptase PCR (qRT-PCR) in 125 cervical tissues including normal cervical epithelium, cervical intraepithelial neoplasia (CIN), and cervical cancer, as well as in five cervical cell lines. Through modulating miR-100 expression using miR-100 inhibitor or mimic in vitro, cell growth, cycle and apoptosis were tested separately by MTT or flow cytometry and meanwhile Polo-like kinase1 (PLK1) mRNA and protein expressions were detected by qRT-PCR and immunoblotting. The expression of PLK1 in 125 cervical tissues was also examined by immunohistochemical staining and the correlation between miR-100 and PLK1 expression in the same tissues was analysed. Finally, HPV-16 E6/E7 expression was modulated by gene transfection and subsequently the level of miR-100 was examined by qRT-PCR.Results: The miR-100 expression showed a significantly and gradually reduced tendency from low-grade CIN, high-grade CIN to cervical cancer tissues and a significant decrease in HPV positive cervical cancer cell lines. The modulation of miR-100 expression remarkably influenced cell proliferation, cycle and apoptosis, as well as the level of PLK1 protein, but not mRNA, in vitro experiments. PLK1 expression was negatively correlated with miR-100 expression in CIN3 and cervical cancer tissues. The modulation of HR-HPV E6/E7 expression did not change miR-100 level.Conclusions: The reduced miR-100 expression participates in the development of cervical cancer at least partly through loss of inhibition to target gene PLK1, which probably occurs in a relative late phase of carcinogenesis. HR-HPV E6/E7 may not directly regulate miR-100 expression in cervical cells. (C) 2011 Elsevier Ltd. All rights reserved.

[The Role of Micrornas in the Pathogenesis of Cervical Cancer and Its Relationship to HPV].

The roles and clinical significance of microRNAs in cervical cancer.

Progressive Mirna Expression Profiles in Cervical Carcinogenesis and Identification of Hpv-Related Target Genes for Mir-29

Mir-2861 Acts As a Tumor Suppressor Via Targeting EGFR/AKT2/CCND1 Pathway in Cervical Cancer Induced by Human Papillomavirus Virus 16 E6

The Role of Gene Sculptor Micrornas in Human Precancerous Lesions.

Micrornas Are Biomarkers of Oncogenic Human Papillomavirus Infections

The Roles of Microrna in Human Cervical Cancer

MicroRNA and Cervical Cancer

Reduced Mir-100 Expression in Cervical Cancer and Precursors and Its Carcinogenic Effect Through Targeting PLK1 Protein.

The Role of MicroRNA in Human Cervical Cancer

Aberrant Expression of Oncogenic and Tumor-Suppressive Micrornas in Cervical Cancer is Required for Cancer Cell Growth

Regulation of cellular miRNA expression by human papillomaviruses.

Mir-187 Overexpression Inhibits Cervical Cancer Progression by Targeting Hpv16 E6

Is Human Papillomavirus Infection the Whole Story?

Profiling of Microrna-Mrna Reveals Roles of Micrornas in Cervical Cancer.

Reduced Mir-34a Expression In Normal Cervical Tissues And Cervical Lesions With High-Risk Human Papillomavirus Infection

Oncogenic HPV Infection Interrupts the Expression of Tumor-Suppressive Mir-34A Through Viral Oncoprotein E6.

Cervical Cancer, Papillomavirus, and miRNA Dysfunction

MicroRNA-183 in Cancer Progression

The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer

The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer